{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:26:26Z","timestamp":1769016386897,"version":"3.49.0"},"reference-count":39,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/dmzx2802","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T07:28:01Z","timestamp":1764314881000},"page":"4795-4810","source":"Crossref","is-referenced-by-count":0,"title":["Patterns and risk factors of intracranial recurrence after surgical resection of brain metastases from malignant tumors"],"prefix":"10.62347","volume":"15","author":[{"given":"Qiang","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.crad.2024.02.015","article-title":"Bench-to-bedside imaging in brain metastases: a road to precision oncology","volume":"79","author":"Shukla","year":"2024","unstructured":"Shukla S, Karbhari A, Rastogi S, Agarwal U, Rai P and Mahajan A. Bench-to-bedside imaging in brain metastases: a road to precision oncology. Clin Radiol 2024; 79: 485-500.","journal-title":"Clin Radiol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Jiang K, Parker M, Materi J, Azad TD, Kamson DO, Kleinberg L, Ye X, Rincon-Torroella J and Bettegowda C. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study. Neurosurg Focus 2023; 55: E3.","DOI":"10.3171\/2023.5.FOCUS23212"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s43856-024-00445-7","article-title":"Estimating the risk of brain metastasis for patients newly diagnosed with cancer","volume":"4","author":"Miccio","year":"2024","unstructured":"Miccio JA, Tian Z, Mahase SS, Lin C, Choi S, Zacharia BE, Sheehan JP, Brown PD, Trifiletti DM, Palmer JD, Wang M and Zaorsky NG. Estimating the risk of brain metastasis for patients newly diagnosed with cancer. Commun Med (Lond) 2024; 4: 27.","journal-title":"Commun Med (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-024-04739-7","article-title":"Defining the role of surgery for patients with multiple brain metastases","volume":"169","author":"Ersoy","year":"2024","unstructured":"Ersoy TF, Brainman D, Coras R, Berger B, Weissinger F, Grote A and Simon M. Defining the role of surgery for patients with multiple brain metastases. J Neurooncol 2024; 169: 317-328.","journal-title":"J Neurooncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10585-024-10274-6","article-title":"Letter: estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection","volume":"41","author":"Suppree","year":"2024","unstructured":"Suppree JS, Kannan S, Hughes DM, Jenkinson MD and Zakaria R. Letter: estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection. Clin Exp Metastasis 2024; 41: 155-157.","journal-title":"Clin Exp Metastasis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13014-021-01854-x","article-title":": current status and recent advances in resection cavity irradiation of brain metastases-roundup to cover all angles","volume":"16","author":"Sarria","year":"2021","unstructured":"Sarria GR, Cifarelli CP, Kahl H and Giordano FA. In regard to Minniti et al.: current status and recent advances in resection cavity irradiation of brain metastases-roundup to cover all angles. Radiat Oncol 2021; 16: 127.","journal-title":"Radiat Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijrobp.2019.10.002","article-title":"Nodular leptomeningeal disease-a distinct pattern of recurrence after postresection stereotactic radiosurgery for brain metastases: a multi-institutional study of interobserver reliability","volume":"106","author":"Turner","year":"2020","unstructured":"Turner BE, Prabhu RS, Burri SH, Brown PD, Pollom EL, Milano MT, Weiss SE, Iv M, Fischbein N, Soliman H, Lo SS, Chao ST, Cox BW, Murphy JD, Li G, Gephart MH, Nagpal S, Atalar B, Azoulay M, Thomas R, Tillman G, Durkee BY, Shah JL and Soltys SG. Nodular leptomeningeal disease-a distinct pattern of recurrence after postresection stereotactic radiosurgery for brain metastases: a multi-institutional study of interobserver reliability. Int J Radiat Oncol Biol Phys 2020; 106: 579-586.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.14791\/btrt.2022.0016","article-title":"Survival outcomes and predictors for recurrence of surgically treated brain metastasis from non-small cell lung cancer","volume":"10","author":"Byun","year":"2022","unstructured":"Byun J, Kim JH, Kim M, Lee S, Kim YH, Hong CK and Kim JH. Survival outcomes and predictors for recurrence of surgically treated brain metastasis from non-small cell lung cancer. Brain Tumor Res Treat 2022; 10: 172-182.","journal-title":"Brain Tumor Res Treat"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"He J, Wang X, Xiao R, Zuo W, Zhang W and Yao H. Risk factors for brain metastases from non-small-cell lung cancer: a protocol for observational study. Medicine (Baltimore) 2021; 100: e24724.","DOI":"10.1097\/MD.0000000000024724"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/cancers17091557","article-title":"Patterns of recurrence after postoperative stereotactic radiotherapy for brain metastases","volume":"17","author":"Crouzen","year":"2025","unstructured":"Crouzen JA, Petoukhova AL, Hakstege M, van Schaik EEMW, Nandoe Tewarie RDS, Nabuurs RJA, Vos MJ, Kerkhof M, van der Vaart T, Koekkoek JAF, Hagenbeek RE, Yildirim FM, Wiltink LM, van der Voort van Zyp NCMG, Kiderlen M, Broekman MLD, Mast ME and Zindler JD. Patterns of recurrence after postoperative stereotactic radiotherapy for brain metastases. Cancers (Basel) 2025; 17: 1557.","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Liu H and Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet 2023; 278-279: 91-103.","DOI":"10.1016\/j.cancergen.2023.10.001"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Shah SN, Shah SS, Shukla G and Shah SA. Conformal partial brain irradiation versus stereotactic radiation therapy in the management of resected brain metastases: a retrospective study. Cureus 2025; 17: e77762.","DOI":"10.7759\/cureus.77762"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Teyateeti A, Brown PD, Mahajan A, Laack NN and Pollock BE. Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery. Neurooncol Adv 2021; 3: vdab036.","DOI":"10.1093\/noajnl\/vdab036"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jad.2023.05.020","article-title":"Association between sleep duration and depression: a mendelian randomization analysis","volume":"335","author":"Liu","year":"2023","unstructured":"Liu H. Association between sleep duration and depression: a mendelian randomization analysis. J Affect Disord 2023; 335: 152-154.","journal-title":"J Affect Disord"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4143\/crt.2014.118","article-title":"Identification of EGFR mutations by immunohistochemistry with EGFR mutation-specific antibodies in biopsy and resection specimens from pulmonary adenocarcinoma","volume":"47","author":"Kim","year":"2015","unstructured":"Kim CH, Kim SH, Park SY, Yoo J, Kim SK and Kim HK. Identification of EGFR mutations by immunohistochemistry with EGFR mutation-specific antibodies in biopsy and resection specimens from pulmonary adenocarcinoma. Cancer Res Treat 2015; 47: 653-660.","journal-title":"Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12885-022-09351-4","article-title":"Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients","volume":"22","author":"Horimoto","year":"2022","unstructured":"Horimoto Y, Ishizuka Y, Ueki Y, Higuchi T, Arakawa A and Saito M. Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients. BMC Cancer 2022; 22: 242.","journal-title":"BMC Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"100532","DOI":"10.1016\/j.jtocrr.2023.100532","article-title":"Predictive value of combined positive score and tumor proportion score for immunotherapy response in advanced NSCLC","volume":"4","author":"Ulas","year":"2023","unstructured":"Ulas EB, Hashemi SMS, Houda I, Kaynak A, Veltman JD, Fransen MF, Radonic T and Bahce I. Predictive value of combined positive score and tumor proportion score for immunotherapy response in advanced NSCLC. JTO Clin Res Rep 2023; 4: 100532.","journal-title":"JTO Clin Res Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/neuonc\/noac246","article-title":"Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with\/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C","volume":"25","author":"Mishima","year":"2023","unstructured":"Mishima K, Nishikawa R, Narita Y, Mizusawa J, Sumi M, Koga T, Sasaki N, Kinoshita M, Nagane M, Arakawa Y, Yoshimoto K, Shibahara I, Shinojima N, Asano K, Tsurubuchi T, Sasaki H, Asai A, Sasayama T, Momii Y, Sasaki A, Nakamura S, Kojima M, Tamaru JI, Tsuchiya K, Gomyo M, Abe K, Natsumeda M, Yamasaki F, Katayama H and Fukuda H. Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with\/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C. Neuro Oncol 2023; 25: 687-698.","journal-title":"Neuro Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1227\/neu.0000000000003239","article-title":"Stereotactic radiosurgery dose reduction for melanoma brain metastases patients on immunotherapy or target therapy: a single-center experience","volume":"96","author":"Tos","year":"2025","unstructured":"Tos SM, Mantziaris G, Shaaban A, Pikis S, Dumot C and Sheehan JP. Stereotactic radiosurgery dose reduction for melanoma brain metastases patients on immunotherapy or target therapy: a single-center experience. Neurosurgery 2025; 96: 1307-1320.","journal-title":"Neurosurgery"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00066-018-1368-1","article-title":"Postoperative local fractionated radiotherapy for resected single brain metastases","volume":"194","author":"Ayas","year":"2018","unstructured":"Ayas AW, Grau S, Jablonska K, Ruess D, Ruge M, Marnitz S, Goldbrunner R and Kocher M. Postoperative local fractionated radiotherapy for resected single brain metastases. Strahlenther Onkol 2018; 194: 1163-1170.","journal-title":"Strahlenther Onkol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/neuonc\/noaa030","article-title":"Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases","volume":"22","author":"Kaufmann","year":"2020","unstructured":"Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY and Ellingson BM. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol 2020; 22: 757-772.","journal-title":"Neuro Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"858756","DOI":"10.3389\/fonc.2022.858756","article-title":"A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction","volume":"12","author":"Liu","year":"2022","unstructured":"Liu H and Weng J. A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction. Front Oncol 2022; 12: 858756.","journal-title":"Front Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Rhun E","year":"2021","unstructured":"Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M and Preusser M; EANO Executive Board and ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol 2021; 32: 1332-1347.","journal-title":"Ann Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13058-024-01789-7","article-title":"Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review","volume":"26","author":"Wallace","year":"2024","unstructured":"Wallace G, Kundalia R, Vallebuona E, Cao B, Kim Y, Forsyth P, Soyano A, Smalley I and Pina Y. Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review. Breast Cancer Res 2024; 26: 55.","journal-title":"Breast Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"847110","DOI":"10.3389\/fonc.2022.847110","article-title":"Surgical management of brain metastasis: challenges and nuances","volume":"12","author":"Ene","year":"2022","unstructured":"Ene CI and Ferguson SD. Surgical management of brain metastasis: challenges and nuances. Front Oncol 2022; 12: 847110.","journal-title":"Front Oncol"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Tewarie IA, Hulsbergen AFC, Jessurun CAC, Rendon LF, Mekary RA, Smith TR and Broekman MLD. Risk factors of second local recurrence in surgically treated recurrent brain metastases: an exploratory analysis. World Neurosurg 2022; 167: e639-e647.","DOI":"10.1016\/j.wneu.2022.08.066"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G and Schiff D. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 2022; 40: 492-516.","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/biomedicines12081792","article-title":"Radiotherapy and systemic treatment for leptomeningeal disease","volume":"12","author":"Frechette","year":"2024","unstructured":"Frechette KM, Breen WG, Brown PD, Sener UT, Webb LM, Routman DM, Laack NN, Mahajan A and Lehrer EJ. Radiotherapy and systemic treatment for leptomeningeal disease. Biomedicines 2024; 12: 1792.","journal-title":"Biomedicines"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"PinaY, Chen A, Arrington J, Macaulay0 R, Tran N, Mokhtari S, Li J, Law V and Sahebjam S. Syst-03 phase 1b study of avelumab and whole brain radiotherapy (wbrt) in patients with leptomeningeal disease (lmd) from epithelial carcinomas: final results and molecular analyses with single cell RNA sequencing. Neurooncol Adv 2023; 5 Suppl 3: 1.","DOI":"10.1093\/noajnl\/vdad070.111"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3892\/ijo.2021.5270","article-title":"Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)","volume":"59","author":"He","year":"2021","unstructured":"He J, Huang Z, Han L, Gong Y and Xie C. Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review). Int J Oncol 2021; 59: 90.","journal-title":"Int J Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40644-021-00410-w","article-title":"Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study","volume":"21","author":"Wang","year":"2021","unstructured":"Wang Y, Xia W, Liu B, Zhou L, Ni M, Zhang R, Shen J, Bai Y, Weng G, Yuan S and Gao X. Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study. Cancer Imaging 2021; 21: 41.","journal-title":"Cancer Imaging"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s12094-022-03050-z","article-title":"Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies","volume":"25","author":"Chhichholiya","year":"2023","unstructured":"Chhichholiya Y, Ruthuparna M, Velagaleti H and Munshi A. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies. Clin Transl Oncol 2023; 25: 1218-1241.","journal-title":"Clin Transl Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11060-022-03977-x","article-title":"Evolving management of HER2 + breast cancer brain metastases and leptomeningeal disease","volume":"157","author":"Mills","year":"2022","unstructured":"Mills MN, King W, Soyano A, Pina Y, Czerniecki BJ, Forsyth PA, Soliman H, Han HS and Ahmed KA. Evolving management of HER2 + breast cancer brain metastases and leptomeningeal disease. J Neurooncol 2022; 157: 249-269.","journal-title":"J Neurooncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"15199","DOI":"10.1002\/cam4.6206","article-title":"Magnetic resonance imaging characteristics of brain metastases in small cell lung cancer","volume":"12","author":"Zhu","year":"2023","unstructured":"Zhu D, Shao Y, Yang Z, Cheng A, Xi Q, Liang X and Chu S. Magnetic resonance imaging characteristics of brain metastases in small cell lung cancer. Cancer Med 2023; 12: 15199-15206.","journal-title":"Cancer Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.brachy.2020.11.009","article-title":"Brachytherapy for lung cancer","volume":"20","author":"Qiu","year":"2021","unstructured":"Qiu B, Jiang P, Ji Z, Huo X, Sun H and Wang J. Brachytherapy for lung cancer. Brachytherapy 2021; 20: 454-466.","journal-title":"Brachytherapy"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11060-025-05023-y","article-title":"Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis","volume":"173","author":"Rashid","year":"2025","unstructured":"Rashid NS, Lamba N, Catalano PJ, Elhalawani H, Tanguturi SK, Rahman R, Haas-Kogan DA, Wen PY and Aizer AA. Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis. J Neurooncol 2025; 173: 609-617.","journal-title":"J Neurooncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/ijc.34135","article-title":"Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: real-world data from a multicentric European cohort","volume":"151","author":"Ratosa","year":"2022","unstructured":"Ratosa I, Dobnikar N, Bottosso M, Dieci MV, Jacot W, Pouderoux S, Ribnikar D, Sinoquet L, Guarneri V, Znidaric T, Darlix A and Griguolo G. Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: real-world data from a multicentric European cohort. Int J Cancer 2022; 151: 1355-1366.","journal-title":"Int J Cancer"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"24170","DOI":"10.1038\/s41598-025-07191-3","article-title":"Survival outcomes among patients with breast cancer and leptomeningeal disease","volume":"15","author":"Id Said","year":"2025","unstructured":"Id Said B, Jerzak KJ, Chen H, Moravan V, Warner E, Myrehaug S, Tseng CL, Detsky J, Dinakaran D, Heyn C, Sahgal A and Soliman H. Survival outcomes among patients with breast cancer and leptomeningeal disease. Sci Rep 2025; 15: 24170.","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"12","author":"JP","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ and Egger M; STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg 2014; 12: 1500-24.","journal-title":"Int J Surg"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/11\/ajcr0168222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:45:08Z","timestamp":1768963508000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/11\/ajcr0168222.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/dmzx2802","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}